Short answer
Zoetis (ZTS) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results and full-year 2026 guidance released August 6, 2026.
Zoetis 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results and full-year 2026 guidance released August 6, 2026
- Press release furnished as Exhibit 99.1, containing the substantive financial details
- Guidance update provides investors with Zoetis’s current full-year outlook
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $2.468B, flat reported and down 1% organically; adjusted net income $781M, down 2% organically
- U.S. revenue fell 7%, with companion-animal sales down 11% amid weaker clinic visits, price sensitivity, competition, and generic pressure
- International revenue grew 8% reported and 6% organically; livestock revenue increased 23% in the U.S., partially offsetting companion-animal weakness
- Full-year revenue guidance cut to $9.120B–$9.320B from $9.680B–$9.960B, implying organic growth of (3)% to (1)%
- Adjusted EPS guidance reduced to $6.15–$6.25 from $6.85–$7.00, while restructuring and acquisition costs rise to approximately $150M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Zoetis 8-K filings
Get the next ZTS 8-K as it lands
Follow ZTS for push alerts, or ask the research agent what this filing means.